Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
HARDER, J, IHORST, G, ENDLICHER, E, REINACHER-SCHICK, A, SCHMOOR, C, GEISSLER, M, HEINEMANN, V, HOFHEINZ, R, MOEHLER, M, BUECHLER, P, KLOEPPEL, G, RÖCKEN, C, BITZER, M, BOECK, S
Published in British journal of cancer (13.03.2012)
Published in British journal of cancer (13.03.2012)
Get full text
Journal Article
The object-oriented DFT program library S/PHI/nX
Boeck, S., Freysoldt, C., Dick, A., Ismer, L., Neugebauer, J.
Published in Computer physics communications (01.03.2011)
Published in Computer physics communications (01.03.2011)
Get full text
Journal Article
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer
HEINEMANN, V, EBERT, M. P, LAUBENDER, R. P, BEVAN, P, MALA, C, BOECK, S
Published in British journal of cancer (05.03.2013)
Published in British journal of cancer (05.03.2013)
Get full text
Journal Article
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method
Haas, M., Waldschmidt, D.T., Stahl, M., Reinacher-Schick, A., Freiberg-Richter, J., Fischer von Weikersthal, L., Kaiser, F., Kanzler, S., Frickhofen, N., Seufferlein, T., Dechow, T., Mahlberg, R., Malfertheiner, P., Illerhaus, G., Kubicka, S., Abdul-Ahad, A., Snijder, R., Kruger, S., Westphalen, C.B., Held, S., von Bergwelt-Baildon, M., Boeck, S., Heinemann, V.
Published in European journal of cancer (1990) (01.03.2021)
Published in European journal of cancer (1990) (01.03.2021)
Get full text
Journal Article
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
von Einem, J. C., Heinemann, V., von Weikersthal, L. Fischer, Vehling-Kaiser, U., Stauch, M., Hass, H. G., Decker, T., Klein, S., Held, S., Jung, A., Kirchner, T., Haas, M., Holch, J., Michl, M., Aubele, P., Boeck, S., Schulz, C., Giessen, C., Stintzing, S., Modest, D. P.
Published in Journal of cancer research and clinical oncology (01.09.2014)
Published in Journal of cancer research and clinical oncology (01.09.2014)
Get full text
Journal Article
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
BOECK, S, WITTWER, C, HEINEMANN, V, HAAS, M, KERN, C, STIEBER, P, NAGEL, D, HOLDENRIEDER, S
Published in British journal of cancer (30.04.2013)
Published in British journal of cancer (30.04.2013)
Get full text
Journal Article
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial
Fietkau, R., Grützmann, R., Wittel, U. A., Croner, R. S., Jacobasch, L., Neumann, U. P., Reinacher-Schick, A., Imhoff, D., Boeck, S., Keilholz, L., Oettle, H., Hohenberger, W. M., Golcher, H., Bechstein, W. O., Uhl, W., Pirkl, A., Adler, W., Semrau, S., Rutzner, S., Ghadimi, M., Lubgan, D.
Published in Strahlentherapie und Onkologie (01.01.2021)
Published in Strahlentherapie und Onkologie (01.01.2021)
Get full text
Journal Article
Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors
Ilhan, Harun, Lindner, S., Todica, A., Cyran, C. C., Tiling, R., Auernhammer, C. J., Spitzweg, C., Boeck, S., Unterrainer, M., Gildehaus, F. J., Böning, G., Jurkschat, K., Wängler, C., Wängler, B., Schirrmacher, R., Bartenstein, P.
Published in European journal of nuclear medicine and molecular imaging (01.04.2020)
Published in European journal of nuclear medicine and molecular imaging (01.04.2020)
Get full text
Journal Article
Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective
Weiss, L., Heinrich, K., Zhang, D., Dorman, K., Rühlmann, K., Hasselmann, K., Klauschen, F., Kumbrink, J., Jung, A., Rudelius, M., Mock, A., Ormanns, Steffen, Kunz, W. G., Roessler, D., Beyer, G., Corradini, S., Heinzerling, L., Haas, M., von Bergwelt-Baildon, M., Boeck, S., Heinemann, V., Westphalen, C. B.
Published in Journal of cancer research and clinical oncology (01.09.2023)
Published in Journal of cancer research and clinical oncology (01.09.2023)
Get full text
Journal Article
The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104-trial
Modest, D.P., Jung, A., Moosmann, N., Laubender, R.P., Giessen, C., Schulz, C., Haas, M., Neumann, J., Boeck, S., Kirchner, T., Heinemann, V., Stintzing, S.
Published in International journal of cancer (15.08.2012)
Published in International journal of cancer (15.08.2012)
Get full text
Journal Article
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’
Haas, M., Siveke, J.T., Schenk, M., Lerch, M.M., Caca, K., Freiberg-Richter, J., Fischer von Weikersthal, L., Kullmann, F., Reinacher-Schick, A., Fuchs, M., Kanzler, S., Kunzmann, V., Ettrich, T.J., Kruger, S., Westphalen, C.B., Held, S., Heinemann, V., Boeck, S.
Published in European journal of cancer (1990) (01.05.2018)
Published in European journal of cancer (1990) (01.05.2018)
Get full text
Journal Article
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104
BOECK, S, JUNG, A, GAULER, T. C, MÄRTEN, A, KLEIN, S, KOJOUHAROFF, G, BARNER, M, GEISSLER, M, GRETEN, T. F, MANSMANN, U, KIRCHNER, T, HEINEMANN, V, LAUBENDER, R. P, NEUMANN, J, EGG, R, GORITSCHAN, C, VEHLING-KAISER, U, WINKELMANN, C, FISCHER VON WEIKERSTHAL, L, CLEMENS, M. R
Published in British journal of cancer (05.02.2013)
Published in British journal of cancer (05.02.2013)
Get full text
Journal Article
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel
Sams, L., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Haas, M., Zhang, D., Westphalen, C. B., Ormanns, S., Metzger, P., Werner, J., Weigert, O., von Bergwelt-Baildon, M., Rataj, F., Kobold, S., Boeck, S.
Published in Clinical & translational oncology (01.11.2021)
Published in Clinical & translational oncology (01.11.2021)
Get full text
Journal Article
Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult
Boeck, S, Haas, M, Ormanns, S, Kruger, S, Siveke, J T, Heinemann, V
Published in British journal of cancer (14.10.2014)
Published in British journal of cancer (14.10.2014)
Get full text
Journal Article
Mismatch-repair-deficient metastatic pancreatic ductal adenocarcinoma with a germline PALB2 mutation: unusual genetics, unusual clinical course
Boeck, S., Mehraein, Y., Ormanns, S., Kruger, S., Westphalen, C.Benedikt, Haas, M., Jung, A., Kirchner, T., Heinemann, V.
Published in Annals of oncology (01.02.2017)
Published in Annals of oncology (01.02.2017)
Get full text
Journal Article
Repeated mutKRAS ctDNA measurements in patients with advanced pancreatic cancer patients: Kinetics, response prediction and therapy monitoring in comparison to protein-based tumor markers
Kruger, S., Heinemann, V., Ross, C., Diehl, F., Ormanns, S., Liebmann, S., Westphalen, C.B., Haas, M., Jung, A., Kirchner, T., von Bergwelt-Baildon, M., Holdenrieder, S., Boeck, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
Hartlapp, I., Valta-Seufzer, D., Siveke, J.T., Algül, H., Goekkurt, E., Siegler, G., Martens, U.M., Waldschmidt, D., Pelzer, U., Fuchs, M., Kullmann, F., Boeck, S., Ettrich, T.J., Held, S., Keller, R., Anger, F., Germer, C.T., Stang, A., Kimmel, B., Heinemann, V., Kunzmann, V.
Published in ESMO open (01.08.2022)
Published in ESMO open (01.08.2022)
Get full text
Journal Article
P04.03 Immuno-analytics of patients with gastric cancer: impact of systemic polychemotherapy on peripheral T-cell fitness and immunologic features of gastric cancer tissue
Haase, T, Grosser, A, Rohrbacher, L, Weiss, L, Dorman, K, Zhang, D, Gießen-Jung, C, Boeck, S, Heinemann, V, Subklewe, M, Reischer, A
Published in Journal for immunotherapy of cancer (01.03.2024)
Published in Journal for immunotherapy of cancer (01.03.2024)
Get full text
Journal Article